Research plays a central role at International Diabetes Center, allowing us to stay at the forefront of diabetes treatment. Working with National Institutes of Health, members of the healthcare industry and research foundations, we have conducted more than 300 research studies over the past 30 years, including the landmark Diabetes Control and Complications Trial (DCCT) and Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Because of the commitment of research participants, significant advances have been made in the appropriate utilization of cutting-edge technologies, new classes of medications and the organization and function of new models of care to improve diabetes outcomes. The medications, blood glucose meters and other devices used today are only possible because of people who participated in research studies to evaluate those products.
Participating in a study will provide you with insight into the research process. We frequently recruit for short-term research opportunities, usually involving just one visit of a few hours or less to our center. These studies may involve testing new meters, test strips, lancing devices or other diabetes products. Please contact us at 952-993-3500 or toll-free at 888-825-6315 to be added to our research database so we may contact you when an appropriate research study is available.
View our current studies
Patients play an important role in our efforts to revolutionize diabetes treatment and care. It is their experiences that help shape our research, treatment and education programs. People who participate in our research studies can benefit in many ways. These may include:
- Study-related medical care at no cost
- Diabetes supplies and medications at no cost*
- Partial compensation for time and travel*
- Gaining information about new technologies and treatment
- Enhanced diabetes knowledge
- Greater confidence in daily diabetes management
- Satisfaction of helping others who have diabetes
*Varies by study
Background and Purpose
Researchers at Park Nicollet Institute developed the Survey of Early Eating Disorder Signs (SEEDS) to identify people with type 1 diabetes who may be at risk of developing an eating disorder. The purpose of the survey is to provide clinicians and researchers with an assessment tool to determine the signs of developing an eating disorder. Too often such signs are overlooked or attributed to other factors. When identified, interventions can be initiated to prevent or diminish an eating disorder.
Development and Validation
The survey was developed using focus groups of people with type 1 diabetes and an eating disorder. Their openness and candid discussion was helpful in identifying signs that were not observed at the beginning of their eating disorder. This information was used to develop the SEEDS survey. The survey was validated using a total of 280 people with type 1 diabetes and very strong psychometric properties.
More information and a link to the survey will be provided in early 2014.